Overview Long-term Safety of Protopic in Atopic Eczema Status: Completed Trial end date: 2005-06-01 Target enrollment: Participant gender: Summary Patients who have participated in previous studies with Tacrolimus ointment for atopic eczema are entitled to enter this four-year follow study to investigate the safety of treatment with Tacrolimus ointment 0.1% Phase: Phase 3 Details Lead Sponsor: Astellas Pharma IncTreatments: Tacrolimus